B Impact Report

Logo for MANRESANA de MICOBACTERIOLOGIA, S.L

MANRESANA de MICOBACTERIOLOGIA, S.L

Probiotic & nutraceuticals
Certified Since: April, 2016
Location: Badalona, Catalonia, Spain
Sector: Wholesale/Retail

Overall B Impact Scoreinfo_outline

95.0

The B Impact Scores are being compared against all businesses that have completed the B Impact Assessment

Manremyc SL is a spin-off from the “Experimental Tuberculosis (TB) Unit,” a research group developing cutting-edge strategies for the prevention & control of human & animal TB. The company is led by Dr. Pere-Joan Cardona (CEO) and focuses on the development of a probiotic that prevents the exacerbation of the immune response responsible for TB pathology & disease.

The mission of Manremyc is to impact positively and globally on human health by developing novel TB intervention strategies. In that context, becoming part of the B Corp community represents a key milestone toward the achievement of our business & social goals

Becoming a B Corp is the proof of MANREMYC's commitment to its mission. Being able not only to get certified by a third party but also to start a leaning process in how to improve our business practices was our motivation.

Impact Area Scoresinfo_outline